Tilt Biotherapeutics grabs $4.3 mln

Helsinki-based Tilt Biotherapeutics Ltd, an oncolytic immunotherapy startup, has raised $4.3 million in funding. The investors included Lifeline Ventures Ltd, the Finnish Funding Agency for Technology and Innovation and the European Commission.

North AmericaUSBriefs